Fianlimab Clinical Trials
11 recruitingDrug
Phase 210Phase 12
Showing 1–11 of 11 trials
Recruiting
Phase 2
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
Advanced Renal Cell Carcinoma (aRCC)
Brian Rini120 enrolled1 locationNCT07188896
Recruiting
Phase 2
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Advanced Melanoma
Memorial Sloan Kettering Cancer Center88 enrolled12 locationsNCT06594991
Recruiting
Phase 2
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
NSCLCLocally Advanced
Montefiore Medical Center76 enrolled1 locationNCT06865339
Recruiting
Phase 2
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Regeneron Pharmaceuticals220 enrolled50 locationsNCT06787612
Recruiting
Phase 2
Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery
Basal Cell CarcinomaLocally Advanced Basal Cell Carcinoma
Thomas Jefferson University70 enrolled3 locationsNCT05929664
Recruiting
Phase 2
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins44 enrolled1 locationNCT06205836
Recruiting
Phase 2
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center10 enrolled7 locationsNCT06699602
Recruiting
Phase 2
Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Lung Non-Small Cell Carcinoma+2 more
Mayo Clinic60 enrolled1 locationNCT06918132
Recruiting
Phase 1Phase 2
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
Prostate Cancer
University of Wisconsin, Madison60 enrolled1 locationNCT04989946
Recruiting
Phase 1
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Multiple Myeloma
Regeneron Pharmaceuticals317 enrolled42 locationsNCT05137054
Recruiting
Phase 2
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
Muscle-Invasive Bladder CarcinomaBladder Cancer
Columbia University36 enrolled1 locationNCT06571708